Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer

Identifieur interne : 002773 ( Istex/Corpus ); précédent : 002772; suivant : 002774

Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer

Auteurs : Will H. A. Kuijpers ; Frans M. Kaspersen ; Gerrit H. Veeneman ; Constant A. A. Van Boeckel ; Ebo S. Bos

Source :

RBID : ISTEX:742C89F6F82CCA89AA8ED144446D2036AE6B2094
Url:
DOI: 10.1021/bc00019a013

Links to Exploration step

ISTEX:742C89F6F82CCA89AA8ED144446D2036AE6B2094

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
<author>
<name sortKey="Kuijpers, Will H A" sort="Kuijpers, Will H A" uniqKey="Kuijpers W" first="Will H. A." last="Kuijpers">Will H. A. Kuijpers</name>
</author>
<author>
<name sortKey="Kaspersen, Frans M" sort="Kaspersen, Frans M" uniqKey="Kaspersen F" first="Frans M." last="Kaspersen">Frans M. Kaspersen</name>
</author>
<author>
<name sortKey="Veeneman, Gerrit H" sort="Veeneman, Gerrit H" uniqKey="Veeneman G" first="Gerrit H." last="Veeneman">Gerrit H. Veeneman</name>
</author>
<author>
<name sortKey="Van Boeckel, Constant A A" sort="Van Boeckel, Constant A A" uniqKey="Van Boeckel C" first="Constant A. A." last="Van Boeckel">Constant A. A. Van Boeckel</name>
</author>
<author>
<name sortKey="Bos, Ebo S" sort="Bos, Ebo S" uniqKey="Bos E" first="Ebo S." last="Bos">Ebo S. Bos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:742C89F6F82CCA89AA8ED144446D2036AE6B2094</idno>
<date when="1993-01-01" year="1993">1993-01-01</date>
<idno type="doi">10.1021/bc00019a013</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002773</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002773</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
<author>
<name sortKey="Kuijpers, Will H A" sort="Kuijpers, Will H A" uniqKey="Kuijpers W" first="Will H. A." last="Kuijpers">Will H. A. Kuijpers</name>
</author>
<author>
<name sortKey="Kaspersen, Frans M" sort="Kaspersen, Frans M" uniqKey="Kaspersen F" first="Frans M." last="Kaspersen">Frans M. Kaspersen</name>
</author>
<author>
<name sortKey="Veeneman, Gerrit H" sort="Veeneman, Gerrit H" uniqKey="Veeneman G" first="Gerrit H." last="Veeneman">Gerrit H. Veeneman</name>
</author>
<author>
<name sortKey="Van Boeckel, Constant A A" sort="Van Boeckel, Constant A A" uniqKey="Van Boeckel C" first="Constant A. A." last="Van Boeckel">Constant A. A. Van Boeckel</name>
</author>
<author>
<name sortKey="Bos, Ebo S" sort="Bos, Ebo S" uniqKey="Bos E" first="Ebo S." last="Bos">Ebo S. Bos</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Bioconjugate Chemistry</title>
<title level="j" type="abbrev">Bioconjugate Chem.</title>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published">2002</date>
<date>1993</date>
<biblScope unit="vol">4</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="94">94</biblScope>
<biblScope unit="page" to="102">102</biblScope>
</imprint>
<idno type="ISSN">1043-1802</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1043-1802</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex>
<corpusName>acs</corpusName>
<keywords>
<teeft>
<json:string>oligonucleotide</json:string>
<json:string>oligonucleotides</json:string>
<json:string>antisense</json:string>
<json:string>monoclonal</json:string>
<json:string>hybridization</json:string>
<json:string>chem</json:string>
<json:string>radiolabeled</json:string>
<json:string>pretargeting</json:string>
<json:string>disulfide</json:string>
<json:string>maleimide</json:string>
<json:string>absorbance</json:string>
<json:string>thiol</json:string>
<json:string>tributylphosphine</json:string>
<json:string>biochem</json:string>
<json:string>maleimide group</json:string>
<json:string>smcc</json:string>
<json:string>monoclonal antibody</json:string>
<json:string>reductive</json:string>
<json:string>room temperature</json:string>
<json:string>nucleic acid</json:string>
<json:string>conjugation</json:string>
<json:string>radioimmunotherapy</json:string>
<json:string>derivatized</json:string>
<json:string>methanol</json:string>
<json:string>bioconjugate</json:string>
<json:string>equiv</json:string>
<json:string>methylphosphonates</json:string>
<json:string>oligodeoxynucleotides</json:string>
<json:string>tetrahedron</json:string>
<json:string>phosphate buffer</json:string>
<json:string>functionalized</json:string>
<json:string>agrawal</json:string>
<json:string>antisense oligonucleotides</json:string>
<json:string>tumor cell</json:string>
<json:string>uridine</json:string>
<json:string>bifunctional</json:string>
<json:string>sephadex</json:string>
<json:string>filtration</json:string>
<json:string>hplc</json:string>
<json:string>bioconjugate chem</json:string>
<json:string>nacl</json:string>
<json:string>unreacted</json:string>
<json:string>murine</json:string>
<json:string>nucleic</json:string>
<json:string>bead</json:string>
<json:string>antibody conjugate</json:string>
<json:string>tetrahedron lett</json:string>
<json:string>bifunctional antibody</json:string>
<json:string>novel approach</json:string>
<json:string>disulfide bond</json:string>
<json:string>sephadex column</json:string>
<json:string>reaction mixture</json:string>
<json:string>gene expression</json:string>
<json:string>reagent</json:string>
<json:string>free thiol</json:string>
<json:string>uridine moiety</json:string>
<json:string>reductive amination</json:string>
<json:string>conjugate preparation</json:string>
<json:string>sodium periodate</json:string>
<json:string>free thiol group</json:string>
<json:string>macmillan press</json:string>
<json:string>antisense inhibitor</json:string>
<json:string>functionalized antibody</json:string>
<json:string>hybridization buffer</json:string>
<json:string>sodium cyanoborohydride</json:string>
<json:string>analogue</json:string>
<json:string>equimolar amount</json:string>
<json:string>radiolabeled monoclonal antibody</json:string>
<json:string>normal tissue uptake ratio</json:string>
<json:string>specific hybridization</json:string>
<json:string>specific activity</json:string>
<json:string>sepharose bead</json:string>
<json:string>nonreducing condition</json:string>
<json:string>total amount</json:string>
<json:string>hplc analysis</json:string>
<json:string>unreacted maleimide group</json:string>
<json:string>antigen binding study</json:string>
<json:string>murine iggi</json:string>
<json:string>optimal tumor</json:string>
<json:string>conjugate</json:string>
<json:string>antibody</json:string>
<json:string>imaging</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>KUIJPERS Will H. A.</name>
</json:item>
<json:item>
<name>KASPERSEN Frans M.</name>
</json:item>
<json:item>
<name>VEENEMAN Gerrit H.</name>
</json:item>
<json:item>
<name>VAN BOECKEL Constant A. A.</name>
</json:item>
<json:item>
<name>BOS Ebo S.</name>
</json:item>
</author>
<arkIstex>ark:/67375/TPS-RNJSP7BW-T</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Article</json:string>
</originalGenre>
<qualityIndicators>
<score>7.012</score>
<pdfWordCount>7439</pdfWordCount>
<pdfCharCount>49576</pdfCharCount>
<pdfVersion>1.6</pdfVersion>
<pdfPageCount>9</pdfPageCount>
<pdfPageSize>615.84 x 801.6 pts</pdfPageSize>
<pdfWordsPerPage>827</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>false</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<title>Bioconjugate Chemistry</title>
<language>
<json:string>unknown</json:string>
</language>
<issn>
<json:string>1043-1802</json:string>
</issn>
<publisherId>
<json:string>bc</json:string>
</publisherId>
<volume>4</volume>
<issue>1</issue>
<pages>
<first>94</first>
<last>102</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<ark>
<json:string>ark:/67375/TPS-RNJSP7BW-T</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - chemistry, organic</json:string>
<json:string>2 - chemistry, multidisciplinary</json:string>
<json:string>2 - biochemistry & molecular biology</json:string>
<json:string>2 - biochemical research methods</json:string>
</wos>
<scienceMetrix>
<json:string>1 - natural sciences</json:string>
<json:string>2 - chemistry</json:string>
<json:string>3 - organic chemistry</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Physical Sciences</json:string>
<json:string>2 - Chemistry</json:string>
<json:string>3 - Organic Chemistry</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Pharmaceutical Science</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string>
<json:string>3 - Pharmacology</json:string>
<json:string>1 - Physical Sciences</json:string>
<json:string>2 - Engineering</json:string>
<json:string>3 - Biomedical Engineering</json:string>
<json:string>1 - Physical Sciences</json:string>
<json:string>2 - Chemical Engineering</json:string>
<json:string>3 - Bioengineering</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Biotechnology</json:string>
</scopus>
</categories>
<publicationDate>1993</publicationDate>
<doi>
<json:string>10.1021/bc00019a013</json:string>
</doi>
<id>742C89F6F82CCA89AA8ED144446D2036AE6B2094</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/bundle.zip</uri>
</json:item>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/fulltext.txt</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>American Chemical Society</publisher>
<date>1993</date>
</publicationStmt>
<notesStmt>
<note type="content-type" source="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note>
<note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
<author xml:id="author-0000">
<persName>
<surname>Kuijpers</surname>
<forename type="first">Will H. A.</forename>
</persName>
</author>
<author xml:id="author-0001">
<persName>
<surname>Kaspersen</surname>
<forename type="first">Frans M.</forename>
</persName>
</author>
<author xml:id="author-0002">
<persName>
<surname>Veeneman</surname>
<forename type="first">Gerrit H.</forename>
</persName>
</author>
<author xml:id="author-0003">
<persName>
<surname>Van Boeckel</surname>
<forename type="first">Constant A. A.</forename>
</persName>
</author>
<author xml:id="author-0004">
<persName>
<surname>Bos</surname>
<forename type="first">Ebo S.</forename>
</persName>
</author>
<idno type="istex">742C89F6F82CCA89AA8ED144446D2036AE6B2094</idno>
<idno type="ark">ark:/67375/TPS-RNJSP7BW-T</idno>
<idno type="DOI">10.1021/bc00019a013</idno>
</analytic>
<monogr>
<title level="j" type="main">Bioconjugate Chemistry</title>
<title level="j" type="abbrev">Bioconjugate Chem.</title>
<idno type="publisher-id">bc</idno>
<idno type="coden">bcches</idno>
<idno type="ISSN">1043-1802</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published">2002</date>
<date>1993</date>
<biblScope unit="vol">4</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="94">94</biblScope>
<biblScope unit="page" to="102">102</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.41" when="2020-04-06">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc>
<textClass ana="subject">
<keywords scheme="document-type-name">
<term>Article</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="2020-04-06" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus acs not found" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:document>
<article specific-use="acs2jats-2.1.12" xml:lang="en" dtd-version="1.1">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">bc</journal-id>
<journal-id journal-id-type="coden">bcches</journal-id>
<journal-title-group>
<journal-title>Bioconjugate Chemistry</journal-title>
<abbrev-journal-title>Bioconjugate Chem.</abbrev-journal-title>
</journal-title-group>
<issn publication-format="print">1043-1802</issn>
<publisher>
<publisher-name>American Chemical Society</publisher-name>
</publisher>
<self-uri xlink:type="simple">pubs.acs.org/bc</self-uri>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1021/bc00019a013</article-id>
<article-categories>
<subj-group subj-group-type="document-type-name">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kuijpers</surname>
<given-names>Will H. A.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kaspersen</surname>
<given-names>Frans M.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Veeneman</surname>
<given-names>Gerrit H.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Van Boeckel</surname>
<given-names>Constant A. A.</given-names>
</name>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bos</surname>
<given-names>Ebo S.</given-names>
</name>
</contrib>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic">
<day>1</day>
<month>05</month>
<year>2002</year>
</pub-date>
<pub-date date-type="issue-pub">
<day>1</day>
<month>01</month>
<year>1993</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<fpage>94</fpage>
<lpage>102</lpage>
<history></history>
<custom-meta-group>
<custom-meta xlink:type="simple">
<meta-name>document-id-backfile</meta-name>
<meta-value>bc00019a013</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
</titleInfo>
<titleInfo contentType="CDATA">
<title>Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer</title>
</titleInfo>
<name type="personal">
<namePart type="family">KUIJPERS</namePart>
<namePart type="given">Will H. A.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="family">KASPERSEN</namePart>
<namePart type="given">Frans M.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="family">VEENEMAN</namePart>
<namePart type="given">Gerrit H.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="family">VAN BOECKEL</namePart>
<namePart type="given">Constant A. A.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="family">BOS</namePart>
<namePart type="given">Ebo S.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>American Chemical Society</publisher>
<dateIssued encoding="w3cdtf">1993-01-01</dateIssued>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<relatedItem type="host">
<titleInfo>
<title>Bioconjugate Chemistry</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Bioconjugate Chem.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">1043-1802</identifier>
<identifier type="PublisherID">bc</identifier>
<identifier type="coden">BCCHES</identifier>
<identifier type="uri">pubs.acs.org/bc</identifier>
<part>
<date>1993</date>
<detail type="volume">
<caption>vol.</caption>
<number>4</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>94</start>
<end>102</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">742C89F6F82CCA89AA8ED144446D2036AE6B2094</identifier>
<identifier type="ark">ark:/67375/TPS-RNJSP7BW-T</identifier>
<identifier type="DOI">10.1021/bc00019a013</identifier>
<accessCondition type="use and reproduction" contentType="restricted">© American Chemical Society. All rights reserved.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-X5HBJWF8-J">acs</recordContentSource>
<recordOrigin>Converted from (version 1.2.10) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2020-04-10</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/TPS-RNJSP7BW-T/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002773 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002773 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:742C89F6F82CCA89AA8ED144446D2036AE6B2094
   |texte=   Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021